ETSU Research Corporation
Stories | 2681 CORE Accelerator

Spartan Health Science Nears Commercial Launch After Year of Growth

With private investment, its first manufactured product, and continued support from 2681 CORE Accelerator, the Northeast Tennessee startup is preparing for commercial sales in 2027.

Portrait of David Arapakos, founder of Spartan Health Science, against a softly blurred office background.
David Arapakos, founder of Spartan Health Science. Born and raised in the Tri-Cities, he has built much of his education and career in Tennessee.

In just 12 months, Spartan Health Science has moved from securing private investment to manufacturing and packaging its first commercial product.

Led by founder David Arapakos, the Northeast Tennessee startup is preparing to bring its heartburn relief product to market, with initial sales and distribution anticipated in late Q1 2027.

Arapakos studied chemistry at Northeast State Community College before earning business degrees from the University of Tennessee, Knoxville. His professional experience includes time at Eastman and more than 17 years with Crown Laboratories, now Revance.

Now, he is drawing on that experience to build a business of his own. Strategic partnerships, professional expertise, and support from 2681 CORE Accelerator are helping move Spartan Health Science forward.

Connections That Made a Difference

Arapakos credits 2681 CORE with meaningful support throughout the company's development. The support came in three forms: professional expertise, strategic connections, and a collaborative workspace.

Through 2681 CORE, Arapakos connected with the ETSU Research Corporation leadership team. That connection included a patent attorney who guided him as he prepared and filed Spartan Health Science's first provisional patent application. The team also helped the company establish an office at Valleybrook Applied Innovation Complex, a place to work alongside the 2681 CORE team and other entrepreneurs.

"2681 CORE has been more than a resource for my business. It's been a genuine support system, with people who are invested in my success."

David Arapakos, founder, Spartan Health Science

Staying Lean Through Strategic Partnerships and AI

With more than two decades of entrepreneurial experience, Arapakos knows that managing costs matters as much as building the product.

Spartan Health Science does not own its own manufacturing, warehousing, or distribution facilities. It works through established partners instead. This keeps the company lean and lets it put its resources into commercialization and growth.

Arapakos also uses AI to streamline daily operations, which helps him handle routine tasks without adding overhead. Looking back, he says he would have adopted the technology sooner.

The Next Chapter: Retail Distribution and Consumer Adoption

With its first commercial batch manufactured and packaged, the company is shifting its focus to retail placement, consumer adoption, and expanded marketing.

Arapakos plans to grow distribution through established service partners while keeping the operating structure lean. Over the long term, he intends to build a documented record of business performance and growth. That record could support a future divestment opportunity.

As the company prepares for its anticipated late Q1 2027 launch, Arapakos is focused on the next challenge: turning a manufactured product into a successful consumer brand.

Bring us a problem. We help find the solution.

Startups, faculty, and industry partners work with 2681 CORE, the Innovation Lab, and Valleybrook to move from idea to market.

Learn How to Partner Explore 2681 CORE